RESEARCH & DEVELOPMENT
Sparsha Pharma International Private Limited has a strong R&D Unit with a good number of research staff continuously working on designing and developing the various types of Transdermal patches. This R&D facility is recognized by the Department of Scientific and Industrial Research (DSIR) which is the part of the Ministry of Science and Technology, Government of India.
SPARSHA CAPABILITIES
Our application solutions in transdermal and topical patches, as well as sublingual dissolvable films, are based on Sparsh's more than three decades of Matrix formulation expertise. For instance, our past experience of formulation and production enabled numerous top brands benefits a substantial competitive edge by delivering OTC lidocaine for up to 24 hours from a single, thin patch.
We have expertise with the Matrix technology in a variety of therapeutic fields, including the central nervous system, pain control, oncology, nausea/motion sickness, oncology, and addiction. For experience in over-the-counter (OTC) and transdermal products that will provide their products a competitive edge in the market, thus many top companies turn towards Sparsha Pharma. The 4% lidocaine formulations from Sparsha provide for consistent drug delivery for up to 24 hours in a thinner, smaller, and more comfortable patch design than the bulkier hydrogel 8-hour and 12-hour OTC patches. We have three decades of transdermal experience and our approach to unique in formulation and performance solutions.
If you would like to know more about our specific capabilities, please contact us at Sparsha Pharma International Pvt. Ltd. , #8-2-408, 4th Floor, Meenakshi House, Road Number 7, Banjara Hills, Hyderabad, Telangana State 500034. India. Tel: +91-40-23352580 ; Email: info@sparsha.com, website: www.sparsha.com
Tasks include formulation development, scale up design, manufacturing process development, and analytical method development.
Sparsha Pharma is willing to discuss
- Contract manufacturing service for clinical samples
- Analytical method development/validation
- Analytical method transfer.
Therapeutic Category | Status | Indication |
---|---|---|
Pain management | Formulation development | Pain relief |
OTC | Formulation development | Pain relief |
Formulation development | Smoking cessation |